The “critical triad” of two key stakeholders and social media This past fall, we published a blog post titled “The Intersection of KOLs, Advocacy Networks,
Over the past two decades we have worked with leading pharmaceutical and medical device companies around the world to identify and map the key opinion leaders
Balancing the cure with the care When a pharmacy employee asked whether she’d like to donate during Breast Cancer Awareness Month, comedian Nicole Osborne, a
The threat of COVID-19 In 1918, 50-100 million people around the world succumbed to the “Spanish Flu” (that’s more human lives than we lost in
As children, we remember hearing that “an apple a day keeps the doctor away.” While this Welsh proverb may not be based on scientific evidence,
The most effective accountable care organizations or ACOs, in 2019 are leaders in innovation and communication. They are assuming downside risk, and the model is
Health care spending in the United States is increasing faster than the gross domestic product. This trend is obviously neither preferable nor sustainable. And all
The life science industry is on a never-ending quest to engage the right stakeholders. Most healthcare executives already realize the need for identifying and mapping
The world is becoming more connected and consumers now have virtually limitless access to medical information. Social platforms have opened up a form of peer
It’s “high” time pharma executives embrace the promise of legal medical cannabis products. They hold much promise, therapeutically and economically. Medical cannabis has strong support
